EUVITRO SLU

Their core work

EUVITRO SLU, operating as Clinica Eugin, is a Barcelona-based fertility clinic and reproductive medicine company specializing in in vitro fertilization (IVF) and oocyte biology. In H2020, they serve as an industry training host for early-stage and postdoctoral researchers through Marie Skłodowska-Curie programmes, providing real-world clinical and laboratory environments for reproductive science. Their contribution bridges the gap between academic oocyte research and clinical assisted reproduction practice.

What they specialise in

How they've shifted over time

With only three projects spanning 2016–2019 start dates, the evolution is modest but visible. The earliest project (DivIDe, 2016) focused broadly on cell division mechanisms in human oocytes with a multidisciplinary angle including synthetic biology. By 2019, EUROVA narrows sharply onto applied oocyte biology — fertility, oocyte maturation, ovulation, and IVF across species (cow, mouse, human) — signaling a shift from fundamental cell biology toward translational reproductive medicine.

Moving from fundamental oocyte science toward translational fertility research and IVF applications, making them an increasingly relevant industry partner for reproductive medicine training networks.

How they like to work

EUVITRO never coordinates — they join as a participant or third party, consistent with their role as an industry clinic hosting researchers rather than leading academic consortia. With 25 unique partners across 11 countries from just 3 projects, they operate within large MSCA training networks (typically 10-15 partners). This suggests they are a valued but selective industry host: easy to integrate into large consortia but not a project driver.

Collaborates with 25 partners across 11 countries through MSCA training networks, reflecting broad European reach typical of ITN consortia. Their network is academically anchored, with EUVITRO providing the private-sector clinical complement.

What sets them apart

As a working IVF clinic participating in EU research training, EUVITRO offers something most academic partners cannot: direct access to clinical reproductive medicine workflows, patient-derived biological material, and real-world IVF laboratory conditions. For consortium builders in reproductive biology, they provide the essential industry-clinical bridge that MSCA programmes specifically require. Few fertility clinics in Europe have this track record of structured participation in EU training networks.

Highlights from their portfolio

• EUROVA
  Largest funded project (EUR 501,810), focused squarely on oocyte biology across species with direct IVF applications — their most thematically aligned project.
• DivIDe
  Combines human oocyte research with synthetic biology approaches, showing an unusual multidisciplinary scope for a fertility clinic.